Reliance Global Group Stock Price, News & Analysis
Company Description
Reliance Global Group, Inc. is a Nasdaq-listed holding company that combines insurance agency operations, InsurTech platforms and strategic venture investments. The company has historically focused on acquiring, owning and actively managing wholesale and retail insurance agencies, with insurance commissions forming the core revenue model of its insurance operations. Reliance Global Group is incorporated in Florida and is headquartered in Lakewood, New Jersey.
The company’s operating foundation includes insurance and InsurTech activities built around independent insurance agencies and agency distribution. Its RELI Exchange platform is an InsurTech platform for independent insurance agencies. The platform is designed to support agency recruitment, customer acquisition and agent productivity through a centralized operating environment that includes pipeline stages, task management and communication tracking.
Reliance Global Group also operates EZRA International Group, a strategic growth platform focused on identifying, acquiring and building majority or controlling stakes in high-growth technology companies. The platform is intended to complement the company’s insurance business through active ownership and disciplined capital allocation across adjacent verticals. Recent company materials describe technology and life sciences as areas of focus within this ownership-driven model.
Within technology, Reliance has reported an equity position in Enquantum Ltd., a developer of post-quantum cryptographic solutions and quantum-resilient encryption technology for high-performance environments. The company has described its Enquantum investment as milestone-based, with ownership and governance participation increasing as defined technical and commercial milestones are met.
Within life sciences, Reliance formed LifeSci Global Group LLC, a Delaware limited liability company in which the company holds approximately 51% of the membership interests. LifeSci Global was formed to identify and make investments in healthcare-related companies. Its initial investment is in Innervate Radiopharmaceuticals LLC, a company focused on radiopharmaceutical products and related technologies. Innervate’s lead asset, 18F-mFBG, is being developed as a PET imaging agent for neuroblastoma.
The company’s public-company profile therefore reflects a dual operating structure: an insurance and InsurTech base centered on agency distribution, and a strategic ventures platform centered on ownership positions in technology and healthcare-related businesses. Reliance Global Group’s common stock trades on Nasdaq under the symbol EZRA.
Stock Performance
Reliance Global Group (EZRA) stock last traded at $3.88, up 1.80% from the previous close. Over the past 12 months, the stock has lost 64.0%. At a market capitalization of $2.2M, EZRA is classified as a micro-cap stock with approximately 555.8K shares outstanding.
EZRA Rankings
Latest News
Reliance Global Group has 10 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 7 with negative movement. Key topics include stock split, earnings, conferences, partnership. View all EZRA news →
SEC Filings
Reliance Global Group has filed 5 recent SEC filings, including 3 Form 8-K, 1 Form 10-Q, 1 Form 424B3. The most recent filing was submitted on May 14, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all EZRA SEC filings →
Insider Radar
Insider buying activity at Reliance Global Group over the past 90 days may reflect management confidence in the company's direction. Institutional investors and analysts often monitor insider purchases as a potential bullish indicator for the stock.
Financial Highlights
Reliance Global Group generated $12.4M in revenue over the trailing twelve months, operating income reached -$9.0M (-72.5% operating margin), and net income was -$7.0M, reflecting a -56.2% net profit margin. Diluted earnings per share stood at $-1.28. The company generated -$3.1M in operating cash flow. With a current ratio of 1.78, the balance sheet reflects a strong liquidity position.
Upcoming Events
Warrants expiration
Warrants expiration
Reliance Global Group has 2 upcoming scheduled events. The next event, "Warrants expiration", is scheduled for January 29, 2028 (in 610 days). 2 of the upcoming events are financial in nature, such as earnings calls or quarterly results. Investors can track these dates to stay informed about potential catalysts that may affect the EZRA stock price.
Short Interest History
Short interest in Reliance Global Group (EZRA) currently stands at 548.3 thousand shares, down 62.2% from the previous reporting period, representing 106.5% of the float. Over the past 12 months, short interest has decreased by 23.4%. This high level of short interest suggests significant bearish sentiment among traders.
Days to Cover History
Days to cover for Reliance Global Group (EZRA) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.
EZRA Company Profile & Sector Positioning
Reliance Global Group (EZRA) operates in the Insurance Brokers industry within the broader Insurance Agents, Brokers & Service sector and is listed on the NASDAQ.